Used in research and development as a potent and selective agonist for the free fatty acid receptor 4 (FFAR4), also known as GPR120. It plays a significant role in studying metabolic disorders, including diabetes and obesity, by modulating insulin sensitivity and glucose homeostasis. Additionally, it is utilized in preclinical studies to explore its anti-inflammatory effects and potential therapeutic applications in conditions like atherosclerosis and non-alcoholic fatty liver disease. Its ability to activate FFAR4 makes it a valuable tool for understanding signaling pathways and developing targeted treatments for metabolic and inflammatory diseases.